N/A N=26 Transcranial Direct Current Stimulation Therapy for Major Depression
Major Depressive Disorder
Primary: Clinical Response — 22 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=327 Community-Based, Client-Centered Prevention Homes to Address the Rural Opioid Epidemic- Aim 3
Drug Use Disorders · Hepatitis C · Harm Reduction
Primary: Change in the Addiction Treatment Accessibility and Utilization as Assessed by Change in Likert Scale — 1.26; 1.07; 1.12; 1.03 score on a scale — p=0.84
N/A N=22 A Prospective Trial of Ayurveda for Coronary Artery Disease
Coronary Artery Disease
Primary: Participants With Arterial Stiffness Were Measured as Pulse Wave Velocity Meters/Second — 19 Participants
N/A N=137 Beige Fat, Energy, and the Natriuretic Peptide System
Obesity
Primary: Adipose Tissue Gene Expression of UCP1 (Uncoupling Protein 1)- Differences by Obesity Status — 7.79; 24.33 fold change — p=<0.01
N/A N=43 Prevention of Falls in the Elderly Population
Accidental Falls
Primary: Change in Mean Survey Score for Providers' Self-reported View on Vitamin Deficiency as a Cause of Falls — 4.23; 3.44 score on a scale
Phase 1 N=175 A Study of Ramucirumab Plus Pembrolizumab in Participants With Gastric or GEJ Adenocarcinoma, NSCLC, Transitional Cell Carcinoma of the Urothelium, or Biliary Tract Cancer
Gastric Adenocarcinoma · Adenocarcinoma of the Gastroesophageal Junction · Non-small Cell Lung Cancer
Primary: Phase 1a: Number of Participants Who Experienced Dose-Limiting Toxicities (DLTs) — 1; 0 participants
N/A N=10 Feasibility Study of FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases
Bone Metastasis
Primary: Workflow Feasibility — 15.8 minutes
Phase 2 N=93 Study to Evaluate the Efficacy and Safety of Once-Weekly Oral NBI-1065846 in the Treatment of Anhedonia in MDD
Anhedonia · Major Depressive Disorder
Primary: Change in Anhedonia Severity, as Measured by Change in DARS Score From Baseline to Day 57 — 17.4; 13.5 units on a scale — p=0.8663
N/A N=180 Investigating Trends in Quality of Life in Patients With Idiopathic Pulmonary Fibrosis (IPF) Under Treatment With Nintedanib
Idiopathic Pulmonary Fibrosis
Primary: Mean Change From Baseline in Health Related Quality of Life (HRQoL) Using SGRQ Score at 3 Months — 2.08; -2.31; 3.37; 2.88 Score on a scale
N/A N=100 Sagittal Plane Shear Index for Planning Lumbar Stenosis Surgery
Lumbar Spinal Stenosis · Spondylolisthesis
Primary: Proportion of Surgical Plans Recorded Prior to the SPSI Report That Are Altered After Integration of SPSI Into the Surgical Planning — 47; 22; 6 Surgical plans
N/A N=15 Neural-net Artificial Pancreas (NAP)
Type1 Diabetes
Primary: Percent of Time-in-Range (TIR) on NAP Versus UMPC. — 86.08; 87.25 Percent of time between 70-180 mg/dl — p=0.2
Phase 3 N=30 Mifepristone for Labor Induction
Induced Vaginal Delivery
Primary: Number of Uterine Contractions — 103; 112; 9; 15 contractions — p=0.44
N/A N=59 Standardized Patients to Measure and Address Intersectional Stigma
Hiv · HIV Infections · AIDS
Primary: MSM Stigma; Domain of Care: Syphilis Testing — 0.078; 0.034 percentage points
N/A N=63 Adaptability and Resilience in Aging Adults-2
Aging · Chronic Low-back Pain
Primary: Session-level Engagement — 6.3 score on a scale
Phase 2 N=163 A Study to Evaluate the Effectiveness and Safety of SKI-O-703 in Patients Experiencing Active Rheumatoid Arthritis Despite Treatment With Conventional Therapies.
Rheumatoid Arthritis
Primary: Change in Disease Activity Score — -0.95; -0.91; -1.06; -1.15 score on a scale